| Year |
Citation |
Score |
| 2022 |
Shih AJ, Jun T, Skol AD, Bao R, Huang L, Vora S, McNerney ME, Hungate EA, Le Beau MM, Larson RA, Elliott A, Lu HM, Huether R, Hernandez F, Stölzel F, ... ... Onel K, et al. Inherited cancer predisposing mutations in patients with therapy-related myeloid neoplasms. British Journal of Haematology. PMID 36349721 DOI: 10.1111/bjh.18543 |
0.702 |
|
| 2022 |
Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, Smedby KE, Kleinstern G, Hjalgrim H, Besson C, Skibola CF, Morton LM, Brooks-Wilson AR, Teras LR, Breeze C, ... ... Onel K, et al. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. PMID 36273105 DOI: 10.1038/s41375-022-01711-0 |
0.304 |
|
| 2021 |
Wang J, Clay-Gilmour AI, Karaesmen E, Rizvi A, Zhu Q, Yan L, Preus L, Liu S, Wang Y, Griffiths E, Stram DO, Pooler L, Sheng X, Haiman C, Van Den Berg D, ... ... Onel K, et al. Genome-Wide Association Analyses Identify Variants in Associated With Acute Myeloid Leukemia and Myelodysplastic Syndrome Susceptibility. Frontiers in Genetics. 12: 554948. PMID 34220922 DOI: 10.3389/fgene.2021.554948 |
0.35 |
|
| 2021 |
Seyed Khoei N, Carreras-Torres R, Murphy N, Gunter MJ, Brennan P, Smith-Byrne K, Mariosa D, Mckay J, O'Mara TA, Jarrett R, Hjalgrim H, Smedby KE, Cozen W, Onel K, Diepstra A, et al. Genetically Raised Circulating Bilirubin Levels and Risk of Ten Cancers: A Mendelian Randomization Study. Cells. 10. PMID 33671849 DOI: 10.3390/cells10020394 |
0.338 |
|
| 2021 |
Bao R, Ng A, Sasaki M, Esai Selvan M, Katti A, Lee H, Huang L, Skol AD, Lavarino C, Salvador H, Klein RJ, Gümüş ZH, Mora J, Onel K. Functional Common and Rare ERBB2 Germline Variants Cooperate in Familial and Sporadic Cancer Susceptibility. Cancer Prevention Research (Philadelphia, Pa.). PMID 33419763 DOI: 10.1158/1940-6207.CAPR-20-0094 |
0.306 |
|
| 2019 |
Din L, Sheikh M, Kosaraju N, Smedby KE, Bernatsky S, Berndt SI, Skibola CF, Nieters A, Wang S, McKay JD, Cocco P, Maynadié M, Foretová L, Staines A, Mack TM, ... ... Onel K, et al. Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes. Genetic Epidemiology. PMID 31407831 DOI: 10.1002/Gepi.22242 |
0.374 |
|
| 2018 |
Zhu Q, Yan L, Liu Q, Zhang C, Wei L, Hu Q, Preus L, Clay-Gilmour AI, Onel K, Stram DO, Pooler L, Sheng X, Haiman CA, Zhu X, Spellman SR, et al. Exomechip Analyses Identify Genes Affecting Mortality after HLA-Matched Unrelated Donor Blood and Marrow Transplantation. Blood. PMID 29610366 DOI: 10.1182/Blood-2017-11-817973 |
0.345 |
|
| 2018 |
Wang J, Clay-Gilmour AI, Karaesmen E, Rizvi A, Zhu Q, Yan L, Preus L, Liu S, Stram D, Pooler L, Cheng X, Haiman C, Van Den Berg D, Webb A, Brock G, ... ... Onel K, et al. Genome Wide Association Analyses Identify Pleiotropic Variants Associated with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Susceptibility Blood. 132: 1500-1500. DOI: 10.1182/Blood-2018-99-110372 |
0.482 |
|
| 2018 |
Karaesmen E, Rizvi A, Preus L, McCarthy PL, Pasquini MC, Singh SK, Singh S, Onel K, Zhu X, Spellman SR, Haiman CA, Stram DO, Pooler L, Sheng X, Zhu Q, et al. Genome-Wide Significant Donor Genetic Associations with Death Due to Disease in AML and MDS Patients in the First 1 Year after BMT are Not Modified by Conditioning Intensity or TBI Biology of Blood and Marrow Transplantation. 24: S79. DOI: 10.1016/J.Bbmt.2017.12.621 |
0.348 |
|
| 2017 |
Clay-Gilmour AI, Hahn T, Preus LM, Onel K, Skol A, Hungate E, Zhu Q, Haiman CA, Stram DO, Pooler L, Sheng X, Yan L, Liu Q, Hu Q, Liu S, et al. Genetic association with B-cell acute lymphoblastic leukemia in allogeneic transplant patients differs by age and sex. Blood Advances. 1: 1717-1728. PMID 29296818 DOI: 10.1182/Bloodadvances.2017006023 |
0.37 |
|
| 2017 |
Hungate EA, Applebaum MA, Skol AD, Vaksman Z, Diamond M, McDaniel L, Volchenboum SL, Stranger BE, Maris JM, Diskin SJ, Onel K, Cohn SL. Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma. Journal of the National Cancer Institute. 109. PMID 29117357 DOI: 10.1093/Jnci/Djx093 |
0.414 |
|
| 2017 |
Morton LM, Sampson JN, Armstrong GT, Chen TH, Hudson MM, Karlins E, Dagnall CL, Li SA, Wilson CL, Srivastava DK, Liu W, Kang G, Oeffinger KC, Henderson TO, Moskowitz CS, ... ... Onel K, et al. Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer. Journal of the National Cancer Institute. 109. PMID 29059430 DOI: 10.1093/Jnci/Djx058 |
0.334 |
|
| 2017 |
Bainer RO, Trendowski MR, Cheng C, Pei D, Yang W, Paugh SW, Goss KH, Skol AD, Pavlidis P, Pui CH, Gilliam TC, Evans WE, Onel K. A p53-regulated apoptotic gene signature predicts treatment response and outcome in pediatric acute lymphoblastic leukemia. Cancer Management and Research. 9: 397-410. PMID 28979163 DOI: 10.2147/Cmar.S139864 |
0.326 |
|
| 2017 |
Hulur I, Skol AD, Gamazon ER, Cox NJ, Onel K. Integrative genetic analysis suggests that skin color modifies the genetic architecture of melanoma. Plos One. 12: e0185730. PMID 28973033 DOI: 10.1371/Journal.Pone.0185730 |
0.771 |
|
| 2017 |
Karaesmen E, Rizvi AA, Preus L, McCarthy PL, Pasquini MC, Onel K, Zhu X, Spellman S, Haiman CA, Stram DO, Pooler L, Sheng X, Zhu Q, Yan L, Liu Q, et al. Replication and validation of genetic polymorphisms associated with survival after allogeneic blood or marrow transplant. Blood. PMID 28811306 DOI: 10.1182/Blood-2017-05-784637 |
0.397 |
|
| 2017 |
Achatz MI, Porter CC, Brugières L, Druker H, Frebourg T, Foulkes WD, Kratz CP, Kuiper RP, Hansford JR, Hernandez HS, Nathanson KL, Kohlmann WK, Doros L, Onel K, Schneider KW, et al. Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 23: e107-e114. PMID 28674119 DOI: 10.1158/1078-0432.Ccr-17-0790 |
0.351 |
|
| 2017 |
Kratz CP, Achatz MI, Brugières L, Frebourg T, Garber JE, Greer MC, Hansford JR, Janeway KA, Kohlmann WK, McGee R, Mullighan CG, Onel K, Pajtler KW, Pfister SM, Savage SA, et al. Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 23: e38-e45. PMID 28572266 DOI: 10.1158/1078-0432.Ccr-17-0408 |
0.382 |
|
| 2017 |
Porter CC, Druley TE, Erez A, Kuiper RP, Onel K, Schiffman JD, Wolfe Schneider K, Scollon SR, Scott HS, Strong LC, Walsh MF, Nichols KE. Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 23: e14-e22. PMID 28572263 DOI: 10.1158/1078-0432.Ccr-17-0428 |
0.353 |
|
| 2017 |
Sucheston-Campbell L, Preus L, McCarthy PL, Pasquini MC, Onel K, Zhu X, Spellman S, Haiman CA, Stram DO, Pooler L, Sheng X, Zhu Q, Yan L, Liu Q, Hu Q, et al. Functional Genetic Variants on 14Q32 Associate with Death Due to Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Within One Year after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (DISCOVeRY-BMT Study) Biology of Blood and Marrow Transplantation. 23: S99-S100. DOI: 10.1016/J.Bbmt.2017.01.041 |
0.324 |
|
| 2017 |
Hahn TE, Preus L, McCarthy PL, Pasquini MC, Onel K, Zhu X, Spellman S, Haiman CA, Stram DO, Pooler L, Sheng X, Zhu Q, Yan L, Liu Q, Hu Q, et al. Novel Genetic Variants Associated with Death Due to Acute Lymphoblastic Leukemia Within One Year after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (DISCOVeRY-BMT Study) Biology of Blood and Marrow Transplantation. 23: S18. DOI: 10.1016/J.Bbmt.2016.12.002 |
0.325 |
|
| 2016 |
Skol AD, Sasaki MM, Onel K. The genetics of breast cancer risk in the post-genome era: thoughts on study design to move past BRCA and towards clinical relevance. Breast Cancer Research : Bcr. 18: 99. PMID 27716388 DOI: 10.1186/S13058-016-0759-4 |
0.352 |
|
| 2016 |
Khankhanian P, Cozen W, Himmelstein DS, Madireddy L, Din L, van den Berg A, Matsushita T, Glaser SL, Moré JM, Smedby KE, Baranzini SE, Mack TM, Lizée A, de Sanjosé S, Gourraud PA, ... ... Onel K, et al. Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis. International Journal of Epidemiology. PMID 26971321 DOI: 10.1093/Ije/Dyv364 |
0.374 |
|
| 2016 |
Hungate EA, Vora SR, Gamazon ER, Moriyama T, Best T, Hulur I, Lee Y, Evans TJ, Ellinghaus E, Stanulla M, Rudant J, Orsi L, Clavel J, Milne E, Scott RJ, ... ... Onel K, et al. A variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology. Nature Communications. 7: 10635. PMID 26868379 DOI: 10.1038/Ncomms10635 |
0.738 |
|
| 2016 |
Zhu# Q, Yan# L, Liu Q, Hu Q, Preus L, Clay AI, Onel K, Stram DO, Pooler LC, Sheng X, Haiman CA, Zhu X, Spellman SR, Pasquini MC, McCarthy PL, et al. Exome Array Analyses Identify New Genes Influencing Survival Outcomes after HLA-Matched Unrelated Donor Blood and Marrow Transplantation Blood. 128: 518-518. DOI: 10.1182/Blood.V128.22.518.518 |
0.378 |
|
| 2016 |
Clay AI, Hahn T, Zhu Q, Yan L, Preus L, Stram DO, Haiman CA, Pooler LC, Sheng X, Onel K, Liu Q, Hu Q, Liu S, Zhu X, Spellman SR, et al. Exome Array Analyses Identify Low-Frequency Germline Variants Associated with Increased Risk of AML in a HLA-Matched Unrelated Donor Blood and Marrow Transplant Population Blood. 128: 42-42. DOI: 10.1182/Blood.V128.22.42.42 |
0.449 |
|
| 2016 |
Hahn TE, Preus L, McCarthy PL, Pasquini MC, Onel K, Zhu X, Spellman S, Haiman C, Stram DO, Pooler L, Sheng X, Zhu Q, Yan L, Liu Q, Hu Q, et al. Genome-Wide Association Study of Cause-Specific Transplant-Related Mortality (TRM) after HLA-Matched Unrelated Donor Allogeneic BMT for Acute Leukemia or Myelodysplastic Syndrome Demonstrates Unique, Non-Overlapping Genetic Associations (Discovery-BMT) Biology of Blood and Marrow Transplantation. 22: S74-S75. DOI: 10.1016/J.Bbmt.2015.11.367 |
0.344 |
|
| 2016 |
Sucheston-Campbell L, Preus L, Spellman S, Pasquini MC, McCarthy PL, Onel K, Zhu X, Haiman C, Stram DO, Pooler L, Sheng X, Zhu Q, Yan L, Liu Q, Hu Q, et al. Functional Single Nucleotide Polymorphisms (SNPs) in the Major Histocompatibility Complex (MHC) Class II Region Are Associated with Overall Survival (OS) after HLA Matched Unrelated Donor BMT: Results from the Discovery-BMT Study Biology of Blood and Marrow Transplantation. 22: S72-S73. DOI: 10.1016/J.Bbmt.2015.11.365 |
0.329 |
|
| 2015 |
Pinto N, Volchenboum SL, Skol AD, Rhodes L, Doan A, Fein-Levy C, Lipton JM, Cunningham JM, Onel K. Establishing a translational genomics infrastructure in pediatric cancer: the GREAT KIDS experience. Personalized Medicine. 12: 221-229. PMID 29771652 DOI: 10.2217/Pme.14.90 |
0.345 |
|
| 2015 |
Henderson TO, Moskowitz CS, Chou JF, Bradbury AR, Neglia JP, Dang CT, Onel K, Novetsky Friedman D, Bhatia S, Strong LC, Stovall M, Kenney LB, Barnea D, Lorenzi E, Hammond S, et al. Breast Cancer Risk in Childhood Cancer Survivors Without a History of Chest Radiotherapy: A Report From the Childhood Cancer Survivor Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26700127 DOI: 10.1200/Jco.2015.62.3314 |
0.311 |
|
| 2015 |
Sasaki MM, Skol AD, Hungate EA, Bao R, Huang L, Kahn SA, Allan JM, Brant SR, McGovern DP, Peter I, Silverberg MS, Cho JH, Kirschner BS, Onel K. Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel Disease. Inflammatory Bowel Diseases. PMID 26480299 DOI: 10.1097/Mib.0000000000000610 |
0.31 |
|
| 2015 |
Bao R, Hernandez K, Huang L, Kang W, Bartom E, Onel K, Volchenboum S, Andrade J. ExScalibur: A High-Performance Cloud-Enabled Suite for Whole Exome Germline and Somatic Mutation Identification. Plos One. 10: e0135800. PMID 26271043 DOI: 10.1371/Journal.Pone.0135800 |
0.326 |
|
| 2015 |
Kutny MA, Alonzo TA, Gamazon ER, Gerbing RB, Geraghty D, Lange B, Heerema NA, Sung L, Aplenc R, Franklin J, Raimondi SC, Hirsch BA, Konkashbaev A, Cox NJ, Onel K, et al. Ethnic variation of TET2 SNP rs2454206 and association with clinical outcome in childhood AML: a report from the Children's Oncology Group. Leukemia. PMID 26126966 DOI: 10.1038/Leu.2015.171 |
0.346 |
|
| 2015 |
Sasaki MM, Skol AD, Bao R, Rhodes LV, Chambers R, Vokes EE, Cohen EE, Onel K. Integrated Genomic Analysis Suggests MLL3 Is a Novel Candidate Susceptibility Gene for Familial Nasopharyngeal Carcinoma. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26014803 DOI: 10.1158/1055-9965.Epi-15-0275 |
0.36 |
|
| 2015 |
Yang XH, Li M, Wang B, Zhu W, Desgardin A, Onel K, de Jong J, Chen J, Chen L, Cunningham JM. Systematic computation with functional gene-sets among leukemic and hematopoietic stem cells reveals a favorable prognostic signature for acute myeloid leukemia. Bmc Bioinformatics. 16: 97. PMID 25887548 DOI: 10.1186/S12859-015-0510-7 |
0.321 |
|
| 2015 |
Hulur I, Gamazon ER, Skol AD, Xicola RM, Llor X, Onel K, Ellis NA, Kupfer SS. Enrichment of inflammatory bowel disease and colorectal cancer risk variants in colon expression quantitative trait loci. Bmc Genomics. 16: 138. PMID 25766683 DOI: 10.1186/S12864-015-1292-Z |
0.776 |
|
| 2015 |
Sucheston-Campbell LE, Clay A, McCarthy PL, Zhu Q, Preus L, Pasquini M, Onel K, Hahn T. Identification and utilization of donor and recipient genetic variants to predict survival after HCT: are we ready for primetime? Current Hematologic Malignancy Reports. 10: 45-58. PMID 25700678 DOI: 10.1007/S11899-014-0246-X |
0.319 |
|
| 2015 |
Lesko AC, Goss KH, Yang FF, Schwertner A, Hulur I, Onel K, Prosperi JR. The APC tumor suppressor is required for epithelial cell polarization and three-dimensional morphogenesis. Biochimica Et Biophysica Acta. 1854: 711-23. PMID 25578398 DOI: 10.1016/J.Bbamcr.2014.12.036 |
0.736 |
|
| 2015 |
Sucheston-Campbell LE, Preus L, Pasquini MC, McCarthy PL, Onel K, Zhu X, Spellman SR, Haiman C, Stram DO, Pooler L, Sheng X, Zhu Q, Yan L, Liu Q, Hu Q, et al. Combined Donor and Recipient Non-HLA Genotypes Show Evidence of Genome Wide Association with Transplant Related Mortality (TRM) after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (URD-BMT) (DISCOVeRY-BMT study) Blood. 126: 61-61. DOI: 10.1182/Blood.V126.23.61.61 |
0.385 |
|
| 2015 |
Hahn T, Preus L, McCarthy PL, Pasquini MC, Onel K, Zhu X, Spellman SR, Haiman C, Stram DO, Pooler L, Sheng X, Zhu Q, Yan L, Liu Q, Hu Q, et al. Genome-Wide Association Study of Overall and Progression-Free Survival after HLA-Matched Unrelated Donor Blood and Marrow Transplantation (DISCOVeRY-BMT study) Blood. 126: 397-397. DOI: 10.1182/Blood.V126.23.397.397 |
0.417 |
|
| 2015 |
Clay AI, Hahn T, Preus L, Onel K, Zhu Q, Haiman C, Stram DO, Pooler LC, Sheng X, Weisdorf D, Yan L, Liu Q, Hu Q, Liu S, Battaglia S, et al. Evidence for Heterogeneous Genetic Associations with Acute Lymphoblastic Leukemia (ALL) By Cytogenetics and Sex in High-Risk Patients Treated with Matched Unrelated Donor Allogeneic Blood or Marrow Transplant (URD-BMT) Blood. 126: 2621-2621. DOI: 10.1182/Blood.V126.23.2621.2621 |
0.414 |
|
| 2015 |
Kupfer SS, Hulur I, Gamazon E, Skol A, Llor X, Onel K, Ellis NA. Abstract 4582: Enrichment of colorectal cancer and inflammatory bowel disease risk variants in colon expression quantitative trait loci in African Americans Cancer Research. 75: 4582-4582. DOI: 10.1158/1538-7445.Am2015-4582 |
0.787 |
|
| 2014 |
Wade MA, Sunter NJ, Fordham SE, Long A, Masic D, Russell LJ, Harrison CJ, Rand V, Elstob C, Bown N, Rowe D, Lowe C, Cuthbert G, Bennett S, Crosier S, ... ... Onel K, et al. c-MYC is a radiosensitive locus in human breast cells. Oncogene. PMID 25531321 DOI: 10.1038/Onc.2014.427 |
0.301 |
|
| 2014 |
Cozen W, Timofeeva MN, Li D, Diepstra A, Hazelett D, Delahaye-Sourdeix M, Edlund CK, Franke L, Rostgaard K, Van Den Berg DJ, Cortessis VK, Smedby KE, Glaser SL, Westra HJ, Robison LL, ... ... Onel K, et al. A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. Nature Communications. 5: 3856. PMID 24920014 DOI: 10.1038/Ncomms4856 |
0.414 |
|
| 2014 |
Henderson TO, Moskowitz CS, Onel K, Bradbury AR, Friedman DN, Chou JF, Bhatia S, Strong LC, Neglia JP, Stovall M, Leisenring WM, Robison LL, Armstrong GT, Diller L, Oeffinger KC. Breast cancer in childhood cancer survivors not treated with chest-directed radiation in the Childhood Cancer Survivor Study (CCSS). Journal of Clinical Oncology. 32: 10009-10009. DOI: 10.1200/Jco.2014.32.15_Suppl.10009 |
0.338 |
|
| 2014 |
Kong Y, Khankhanian P, Himmelstein D, Hwang AE, Rand KA, Li D, Van Den Berg DJ, Diepstra A, Conti DV, Bhatia S, Gourraud P, Glaser SL, Mack TM, Oksenberg J, Onel K, et al. Meta-Analysis of Hodgkin Lymphoma and Asthma Genome-Wide Association Scans reveals common variants in GATA3 Blood. 124: 135-135. DOI: 10.1182/Blood.V124.21.135.135 |
0.372 |
|
| 2014 |
Sucheston-Campbell L, Hahn T, Preus L, Onel K, Zhu X, Liu S, Yan L, Clay A, Tritchler D, Pasquini M, McCarthy P. Abstract 5079: Adjudicating complex phenotypes for use in GWAS: A study of transplant-related mortality (TRM) after unrelated donor hematopoietic cell transplantation (URD-HCT) Cancer Research. 74: 5079-5079. DOI: 10.1158/1538-7445.Am2014-5079 |
0.303 |
|
| 2014 |
Hulur I, Skol A, Onel K. Abstract 1297: The heritability of melanoma differs between light- and dark-skinned individuals of European descent Cancer Research. 74: 1297-1297. DOI: 10.1158/1538-7445.Am2014-1297 |
0.763 |
|
| 2014 |
Hulur I, Skol A, Llor X, Onel K, Ellis NA, Kupfer S. 719 Expression Quantitative Trait Loci Mapping in the Human Colon Gastroenterology. 146: S-125-S-126. DOI: 10.1016/S0016-5085(14)60451-0 |
0.736 |
|
| 2013 |
Shah S, Schrader KA, Waanders E, Timms AE, Vijai J, Miething C, Wechsler J, Yang J, Hayes J, Klein RJ, Zhang J, Wei L, Wu G, Rusch M, Nagahawatte P, ... ... Onel K, et al. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nature Genetics. 45: 1226-31. PMID 24013638 DOI: 10.1038/Ng.2754 |
0.338 |
|
| 2013 |
Morton LM, Dores GM, Tucker MA, Kim CJ, Onel K, Gilbert ES, Fraumeni JF, Curtis RE. Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008. Blood. 121: 2996-3004. PMID 23412096 DOI: 10.1182/Blood-2012-08-448068 |
0.333 |
|
| 2013 |
Elena JW, Travis LB, Simonds NI, Ambrosone CB, Ballard-Barbash R, Bhatia S, Cerhan JR, Hartge P, Heist RS, Kushi LH, Lash TL, Morton LM, Onel K, Pierce JP, Robison LL, et al. Leveraging epidemiology and clinical studies of cancer outcomes: recommendations and opportunities for translational research. Journal of the National Cancer Institute. 105: 85-94. PMID 23197494 DOI: 10.1093/Jnci/Djs473 |
0.32 |
|
| 2013 |
Cozen W, Li D, Timofeeva M, Diepstra A, Hazelett D, Delahaye-Sourdeix M, Edlund CK, Rostgaard K, Berg DJVD, Franke L, Smedby KE, Glaser SL, Westra H, Robison LL, Mack TM, ... ... Onel K, et al. A Meta-Analysis Of Hodgkin Lymphoma Reveals 19p13.3 (TCF3) As a Novel Susceptibility Loc Blood. 122: 626-626. DOI: 10.1182/Blood.V122.21.626.626 |
0.441 |
|
| 2013 |
Applebaum MA, Skol A, Bond G, Onel K. Abstract 429: Damage-induced apoptosis in primary human lymphocytes is a genetic program modified by gender and age. Cancer Research. 73: 429-429. DOI: 10.1158/1538-7445.Am2013-429 |
0.335 |
|
| 2013 |
Sasaki MM, Skol AD, Pugh TJ, Meyerson M, Onel K. Abstract 4018: Whole exome sequencing analysis of familial Medulloblastoma. Cancer Research. 73: 4018-4018. DOI: 10.1158/1538-7445.Am2013-4018 |
0.396 |
|
| 2013 |
Wolak KE, Bainer R, Skol A, Onel K. Abstract 3287: Sensitizing cancer cells to chemotherapy. Cancer Research. 73: 3287-3287. DOI: 10.1158/1538-7445.Am2013-3287 |
0.307 |
|
| 2013 |
Colbert L, Ward CW, Onel K. Abstract 1652: A new approach to study intracellular pathways of metastasis in living tumor cells. Cancer Research. 73: 1652-1652. DOI: 10.1158/1538-7445.Am2013-1652 |
0.336 |
|
| 2012 |
Doçi CL, Mankame TP, Langerman A, Ostler KR, Kanteti R, Best T, Onel K, Godley LA, Salgia R, Lingen MW. Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 31: 15-24. PMID 22123719 DOI: 10.1097/Pgp.0B013E318220Ba16 |
0.348 |
|
| 2012 |
Cozen W, Li D, Best T, Van Den Berg DJ, Gourraud PA, Cortessis VK, Skol AD, Mack TM, Glaser SL, Weiss LM, Nathwani BN, Bhatia S, Schumacher FR, Edlund CK, Hwang AE, ... ... Onel K, et al. A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32. Blood. 119: 469-75. PMID 22086417 DOI: 10.1182/Blood-2011-03-343921 |
0.395 |
|
| 2012 |
Wolak KE, Skol A, Bainer R, Onel K. Abstract 2505: Targeting the p53 response in pediatric B-cell acute lymphoblastic leukemia Cancer Research. 72: 2505-2505. DOI: 10.1158/1538-7445.Am2012-2505 |
0.334 |
|
| 2011 |
Godley LA, Cunningham J, Dolan ME, Huang RS, Gurbuxani S, McNerney ME, Larson RA, Leong H, Lussier Y, Onel K, Odenike O, Stock W, White KP, Le Beau MM. An integrated genomic approach to the assessment and treatment of acute myeloid leukemia. Seminars in Oncology. 38: 215-24. PMID 21421111 DOI: 10.1053/J.Seminoncol.2011.01.003 |
0.322 |
|
| 2011 |
Sucheston L, Witonsky DB, Hastings D, Yildiz O, Clark VJ, Di Rienzo A, Onel K. Natural selection and functional genetic variation in the p53 pathway. Human Molecular Genetics. 20: 1502-8. PMID 21266458 DOI: 10.1093/Hmg/Ddr028 |
0.351 |
|
| 2011 |
Tan YC, Krishnaswamy S, Nandi S, Kanteti R, Vora S, Onel K, Hasina R, Lo F, El-Hashani E, Cervantes G, Robinson M, Hsu H, Kales SC, Lipkowitz S, Karrison T, et al. Correction: CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases Plos One. 6. DOI: 10.1371/annotation/940edb14-522e-4f38-b6c4-7557e9a13d15 |
0.676 |
|
| 2011 |
Onel K, Best T, Yu S. Variants At 6q21 Associated with Radiation-Induced Second Malignancies After Hodgkin Lymphoma Differentially Regulate PRDM1 Expression Following Radiation Exposure Blood. 118: 431-431. DOI: 10.1182/Blood.V118.21.431.431 |
0.385 |
|
| 2011 |
Onel K, Best T, Skol AD, Li D, Kirchhoff T, Yasui Y, Bhatia S, Strong LC, Domchek SM, Nathanson KL, Olopade O, Mack TM, Conti DV, Offit K, Cozen W, et al. Abstract 5092: Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma Cancer Research. 71: 5092-5092. DOI: 10.1158/1538-7445.Am2011-5092 |
0.425 |
|
| 2010 |
Churpek JE, Onel K. Heritability of hematologic malignancies: from pedigrees to genomics. Hematology/Oncology Clinics of North America. 24: 939-72. PMID 20816581 DOI: 10.1016/J.Hoc.2010.06.001 |
0.364 |
|
| 2010 |
Tan YH, Krishnaswamy S, Nandi S, Kanteti R, Vora S, Onel K, Hasina R, Lo FY, El-Hashani E, Cervantes G, Robinson M, Hsu HS, Kales SC, Lipkowitz S, Karrison T, et al. CBL is frequently altered in lung cancers: its relationship to mutations in MET and EGFR tyrosine kinases. Plos One. 5: e8972. PMID 20126411 DOI: 10.1371/Journal.Pone.0008972 |
0.708 |
|
| 2010 |
Best T, Skol AD, Gamazon E, Onel K. A Functional Analysis of Variants Associated with Therapy-Induced Second Malignancies After Hodgkin Lymphoma Identified by a Genome-Wide Scan Blood. 116: 3892-3892. DOI: 10.1182/Blood.V116.21.3892.3892 |
0.435 |
|
| 2010 |
Cozen W, Li D, Best T, Berg DJVD, Skol A, Cortessis VK, Mack TM, Glaser SL, Schumacher F, Weiss L, Nathwani BN, Hwang A, Bhatia S, Strong LC, Robison LL, ... ... Onel K, et al. A Meta-Analysis of Nodular Sclerosis Hodgkin Lymphoma Identifies Risk Loci at 6p21.32 Blood. 116: 2686-2686. DOI: 10.1182/Blood.V116.21.2686.2686 |
0.418 |
|
| 2010 |
Bainer R, Marioni J, Barriero L, Blekhman R, Onel K, Gilad Y. Abstract LB-332: MDM4 transcription is discordantly regulated by common variants of p53 Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-332 |
0.354 |
|
| 2009 |
Vora S, Ellis N, Onel K. Translating genetic questions into clinical answers in acute myeloid leukemia. Leukemia Research. 33: 1448-9. PMID 19631381 DOI: 10.1016/J.Leukres.2009.06.018 |
0.702 |
|
| 2009 |
Knight JA, Skol AD, Shinde A, Hastings D, Walgren RA, Shao J, Tennant TR, Banerjee M, Allan JM, Le Beau MM, Larson RA, Graubert TA, Cox NJ, Onel K. Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility. Blood. 113: 5575-82. PMID 19299336 DOI: 10.1182/Blood-2008-10-183244 |
0.625 |
|
| 2009 |
Onel KB, Huo D, Hastings D, Fryer-Biggs J, Crow MK, Onel K. Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults Lupus. 18: 61-66. PMID 19074170 DOI: 10.1177/0961203308094558 |
0.403 |
|
| 2008 |
Ellis NA, Huo D, Yildiz O, Worrillow LJ, Banerjee M, Le Beau MM, Larson RA, Allan JM, Onel K. MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility. Blood. 112: 741-9. PMID 18426989 DOI: 10.1182/Blood-2007-11-126508 |
0.378 |
|
| 2008 |
Kuptsova N, Chang-Claude J, Kropp S, Helmbold I, Schmezer P, von Fournier D, Haase W, Sautter-Bihl ML, Wenz F, Onel K, Ambrosone CB. Genetic predictors of long-term toxicities after radiation therapy for breast cancer. International Journal of Cancer. Journal International Du Cancer. 122: 1333-9. PMID 18027873 DOI: 10.1002/Ijc.23138 |
0.373 |
|
| 2008 |
Onel K, Knight JA, Skol AD, Tennant TR, Banerjee M, Walgren R, Shao J, Allan JM, Beau MML, Larson RA, Graubert T, Cox NJ. A Genome-Wide Analysis to Identify Novel Susceptibility Loci for Therapy-Related Acute Myeloid Leukemia Blood. 112: 432-432. DOI: 10.1182/Blood.V112.11.432.432 |
0.45 |
|
| 2005 |
Siddiqui R, Onel K, Facio F, Nafa K, Diaz LR, Kauff N, Huang H, Robson M, Ellis N, Offit K. The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds. Familial Cancer. 4: 177-81. PMID 15951970 DOI: 10.1007/S10689-004-1946-5 |
0.326 |
|
| 2004 |
Siddiqui R, Robles Diaz L, Nafa K, Kauff N, Facio F, Huang H, Onel K, Robson M, Ellis N, Offit K. TP53 and CHEK2 *1100delC gene mutation in North American families suggestive Li-Fraumeni syndrome: Memorial Sloan-Kettering experience. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 9537. PMID 28016821 DOI: 10.1200/Jco.2004.22.14_Suppl.9537 |
0.321 |
|
| 2004 |
Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, Onel K, Yip L, Hwang SJ, Strong LC, Lozano G, et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell. 119: 591-602. PMID 15550242 DOI: 10.1016/J.Cell.2004.11.022 |
0.396 |
|
| Show low-probability matches. |